Susannah Gray

Former CFO, Royalty Pharma

Susannah Gray has more than 30 years of healthcare experience specifically in corporate finance and capital markets roles. Most recently, she spent 14 years as EVP, Finance and CFO of Royalty Pharma Management, LLC, before retiring in 2019.

Prior to Royalty Pharma, Ms. Gray served as a managing director and senior analyst covering the healthcare sector of CIBC World Markets’ high yield group from 2002 to 2004, and previously served in similar roles at Merrill Lynch and Chase Securities (predecessor of J.P. Morgan Securities).

Ms. Gray is also a member of the board of directors of 4D Molecular Therapeutics, Theravance Biopharmaceutical and Maravai Life Sciences. She also sits on the board of trustees of Wesleyan University and the Colby College Museum of Art.

Ms. Gray holds an MBA from Columbia University and a BA in social studies from Wesleyan University.